Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Si‐Nan Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8502-2473; OpenAlex author ID A5085141047. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. Co-author DOI 10.1016/j.phymed.2025.157665↗
  2. A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. First author DOI 10.1002/cbdv.202101004↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ming Zhao · 2 shared papers, 2022–2026 · strength 0.48
  2. Weiwei Tao · 1 shared paper, 2026 · strength 0.32
  3. Wei Liu · 1 shared paper, 2026 · strength 0.32
  4. Lu Cai · 1 shared paper, 2026 · strength 0.32
  5. Cheng‐Bin Yang · 1 shared paper, 2022 · strength 0.16
  6. Mingming Xu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.